UnknownNot Applicable

Determinant of Fetal Growth Retardation After Sleeve Gastrectomy: Involvement of Ghrelin

France50 participantsStarted 2023-07-10

Plain-language summary

The aim of the study is to determine, in pregnant women who have undergone sleeve gastrectomy (SG), whether ghrelin changes could be involved in in utero growth restriction (IUGR) and whether therefore a correlation between maternal ghrelin levels and birth weight is observed.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Woman previously operated of sleeve gastrectomy * Pregnant from 3 to 6 months * Having a mono-fetal pregnancy * Coming to consult in day hospital for a nutritional assessment Exclusion Criteria: * Twin pregnancy * Identified cause of IUGR apart from those related to sleeve gastrectomy * Woman who has undergone another bariatric surgery technique * Lack of individual information and collection of the consent form * Problems of understanding * Lack of affiliation to a social security scheme or state medical aid * Patient benefiting from a legal protection measure (with guardians or curators)

What they're measuring

Correlation between ghrelin levels and birth weight of children born to mothers who had a sleeve gastrectomy

Timeframe: 18 months

Trial details

NCT IDNCT05977790

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01

Contact for this trial

Séverine Ledoux, MD

01 47 60 62 50 severine.ledoux@aphp.fr

View on ClinicalTrials.gov More In Utero Growth Retardation trials